Skip to main content
Premium Trial:

Request an Annual Quote

Genetix Snags Microarray Rights from Biomedical Photometrics

NEW YORK, Jan. 11 - Genetix Group has licensed the rights to manufacture and sell microarray scanners owned by Biomedical Photometrics, the company said.

 

The scanners, called aQuire, are intended to complement Genetix' existing arraying robots and to allow the company to sell what it calls complete systems for gene-expression analysis. 

 

Genetix, of New Milford, UK, said it will now provide two platforms: a high-throughput array and analysis system based on the aQuire confocal scanner and its own QArray, and a system using the new smaller QArray Mini and the aQuire Mini scanner.

 

"We are very excited about this new opportunity to extend our product range into the area of high value data acquisition applications," Julian Burke, chief scientific officer of Genetix, said in a statement released on Thursday.

 

The aQuire scanners will be built in Genetix's Hampshire, UK facility, a company spokeswoman said. The units will be sold with the QArray line in Genetix' existing markets in Europe, the US, and Asia.

 

Biomedical Photometrics is based in Waterloo, Canada.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.